SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 12.49 |
| Enterprise Value ($M) | 6.98 |
| Book Value ($M) | 5.05 |
| Book Value / Share | 0.36 |
| Price / Book | 2.47 |
| NCAV ($M) | 4.83 |
| NCAV / Share | 0.35 |
| Price / NCAV | 2.59 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -4.95 |
| Return on Assets (ROA) | -7.44 |
| Return on Equity (ROE) | -460.48 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.55 |
| Current Ratio | 2.55 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 7.93 |
| Assets | 8.16 |
| Liabilities | 3.11 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 3.95 |
| Operating Income | -25.14 |
| Net Income | -24.99 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -24.68 |
| Cash from Investing | -0.02 |
| Cash from Financing | 23.75 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | 4.99 | -47.62 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 138,995 | 452,856 | 30.69 | |
| 242,821 | 640,562 | 37.91 | |
| 458,545 | 1,212,426 | 37.82 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| GLYC – GlycoMimetics, Inc. | GNLX – Genelux Corporation |
| GNPX – Genprex, Inc. | GRCE – Grace Therapeutics, Inc. |
| GTBP – GT Biopharma, Inc. |
Financial data and stock pages provided by
Fintel.io